SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
15-Jun-23 6:06 PM View: | Acutus Medical, Inc. (AFIB) | 15-Jun-23 | Grant | 8,400 | -- | -- | 67% 12.57K to 20.97K | |
31-May-23 7:02 PM View: | Nevro Corp (NVRO) | 28-May-23 | Payment of Exercise | 1,143 | $26.45 | $30,232.40 | (1%) 87.11K to 85.97K | |
09-Mar-23 4:57 PM View: | Nevro Corp (NVRO) | 07-Mar-23 | Grant | 39,282 | -- | -- | 82% 47.83K to 87.11K | |
06-Mar-23 6:43 PM View: | Nevro Corp (NVRO) | 02-Mar-23 | Payment of Exercise | 1,979 | $33.99 | $67,266.20 | (4%) 49.81K to 47.83K | |
02-Mar-23 4:34 PM View: | Nevro Corp (NVRO) | 28-Feb-23 | Payment of Exercise | 4,718 | $31.44 | $148,334.00 | (9%) 54.52K to 49.81K | |
08-Aug-22 8:26 PM View: | Nevro Corp (NVRO) | 06-Aug-22 | Payment of Exercise | 4,365 | $47.11 | $205,635.00 | (7%) 58.89K to 54.52K | |
21-Jun-22 5:41 PM View: | Acutus Medical, Inc. (AFIB) | 16-Jun-22 | Grant | 8,400 | -- | -- | 201% 4.17K to 12.57K | |
04-Mar-22 7:14 PM View: | Nevro Corp (NVRO) | 02-Mar-22 | Payment of Exercise | 2,031 | $71.27 | $144,749.00 | (3%) 60.92K to 58.89K | |
02-Mar-22 9:02 PM View: | Nevro Corp (NVRO) | 28-Feb-22 | Grant | 26,069 | -- | -- | 75% 34.85K to 60.92K | |
10-Aug-21 4:27 PM View: | Nevro Corp (NVRO) | 06-Aug-21 | Payment of Exercise | 4,366 | $119.73 | $522,741.00 | (11%) 39.22K to 34.85K | < 1% |
12-Mar-21 5:45 PM View: | Nevro Corp (NVRO) | 10-Mar-21 | Option Exercise | 750 | $64.95 | $48,712.50 | 2% 39.22K to 39.97K | |
12-Mar-21 5:45 PM View: | Nevro Corp (NVRO) | 10-Mar-21 | Market Option Sale (Planned) | 750 | $148.08 | $111,060.00 | (2%) 39.97K to 39.22K | |
04-Mar-21 7:20 PM View: | Nevro Corp (NVRO) | 02-Mar-21 | Grant | 9,596 | -- | -- | 32% 30.33K to 39.92K | |
04-Mar-21 7:20 PM View: | Nevro Corp (NVRO) | 02-Mar-21 | Payment of Exercise | 706 | $168.11 | $118,686.00 | (2%) 39.92K to 39.22K | |
12-Feb-21 5:29 PM View: | Nevro Corp (NVRO) | 10-Feb-21 | Option Exercise | 750 | $64.95 | $48,712.50 | 2% 30.33K to 31.08K | |
12-Feb-21 5:29 PM View: | Nevro Corp (NVRO) | 10-Feb-21 | Market Option Sale (Planned) | 750 | $182.55 | $136,912.00 | (2%) 31.08K to 30.33K | |
13-Jan-21 4:18 PM View: | Nevro Corp (NVRO) | 11-Jan-21 | Option Exercise | 750 | $64.95 | $48,712.50 | 2% 30.33K to 31.08K | |
13-Jan-21 4:18 PM View: | Nevro Corp (NVRO) | 11-Jan-21 | Market Option Sale (Planned) | 750 | $169.80 | $127,350.00 | (2%) 31.08K to 30.33K | |
14-Dec-20 4:38 PM View: | Nevro Corp (NVRO) | 10-Dec-20 | Option Exercise | 750 | $64.95 | $48,712.50 | 2% 30.33K to 31.08K | (2%) |
14-Dec-20 4:38 PM View: | Nevro Corp (NVRO) | 10-Dec-20 | Market Option Sale (Planned) | 750 | $161.21 | $120,910.00 | (2%) 31.08K to 30.33K | (13%) |
12-Nov-20 5:34 PM View: | Nevro Corp (NVRO) | 10-Nov-20 | Option Exercise | 750 | $64.95 | $48,712.50 | 2% 30.33K to 31.08K | (2%) |
12-Nov-20 5:34 PM View: | Nevro Corp (NVRO) | 10-Nov-20 | Market Option Sale (Planned) | 750 | $170.75 | $128,062.00 | (2%) 31.08K to 30.33K | (7%) |
26-Oct-20 5:11 PM View: | Nevro Corp (NVRO) | 22-Oct-20 | Market Sale (Planned) | 1,817 | $165.00 | $299,805.00 | (6%) 32.15K to 30.33K | (11%) |
21-Oct-20 4:15 PM View: | Nevro Corp (NVRO) | 19-Oct-20 | Market Sale (Planned) | 1,000 | $155.00 | $155,000.00 | (3%) 33.15K to 32.15K | (18%) |
13-Oct-20 6:16 PM View: | Nevro Corp (NVRO) | 13-Oct-20 | Option Exercise | 750 | $64.95 | $48,712.50 | 2% 33.15K to 33.9K | |
13-Oct-20 6:16 PM View: | Nevro Corp (NVRO) | 13-Oct-20 | Market Sale (Planned) | 750 | $151.47 | $113,602.00 | (2%) 33.9K to 33.15K | (20%) |
13-Oct-20 6:16 PM View: | Nevro Corp (NVRO) | 09-Oct-20 | Market Option Sale (Planned) | 750 | $150.00 | $112,500.00 | (2%) 34.15K to 33.4K | (22%) |
13-Oct-20 6:16 PM View: | Nevro Corp (NVRO) | 09-Oct-20 | Market Sale (Planned) | 250 | $150.00 | $37,500.00 | (< 1%) 33.4K to 33.15K | (22%) |
14-Sep-20 4:06 PM View: | Nevro Corp (NVRO) | 10-Sep-20 | Option Exercise | 750 | $64.95 | $48,712.50 | 2% 34.15K to 34.9K | (2%) |
14-Sep-20 4:06 PM View: | Nevro Corp (NVRO) | 10-Sep-20 | Market Option Sale (Planned) | 750 | $139.14 | $104,355.00 | (2%) 34.9K to 34.15K | (31%) |
10-Aug-20 6:55 PM View: | Nevro Corp (NVRO) | 10-Aug-20 | Option Exercise | 750 | $64.95 | $48,712.50 | 2% 34.15K to 34.9K | |
10-Aug-20 6:55 PM View: | Nevro Corp (NVRO) | 10-Aug-20 | Market Option Sale (Planned) | 750 | $140.11 | $105,082.00 | (2%) 34.9K to 34.15K | (30%) |
10-Aug-20 6:55 PM View: | Nevro Corp (NVRO) | 06-Aug-20 | Payment of Exercise | 4,476 | $141.77 | $634,563.00 | (12%) 38.62K to 34.15K | (29%) |
04-Mar-20 6:26 PM View: | Nevro Corp (NVRO) | 02-Mar-20 | Grant | 5,446 | -- | -- | 16% 33.17K to 38.62K | |
17-Jul-19 7:46 PM View: | Nevro Corp (NVRO) | 15-Jul-19 | Grant | 33,175 | -- | -- | 100% 0 to 33.17K | |
08-Oct-15 4:59 PM View: | Thoratec Corp. (THOR) | 08-Oct-15 | Grant | 11,228 | -- | -- | 28% 40.7K to 51.93K | |
08-Oct-15 4:59 PM View: | Thoratec Corp. (THOR) | 08-Oct-15 | Disposition | 51,928 | $63.50 | $3,297,430.00 | (100%) 51.93K to 0 | 69% |
16-Mar-15 7:34 PM View: | Thoratec Corp. (THOR) | 16-Mar-15 | Grant | 13,099 | -- | -- | 47% 27.6K to 40.7K | |
15-Oct-14 6:36 PM View: | Thoratec Corp. (THOR) | 13-Oct-14 | Grant | 27,601 | -- | -- | 100% 0 to 27.6K |